Basic Information
RNALocate ID: | RLID:11002590 |
RNA Symbol: | hsa-miR-342-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-342-3p |
RNA ID: | miRBase:MIMAT0000753 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23663360 |
Tissue/Cell Line: | Plasma |
Method: | Next-generation RNA sequencing |
Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002053 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01002054 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01002055 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01002056 | Nucleolus | HeLa cells | 23940654 |
RLID:01002057 | Nucleolus | Breast adenocarcinoma cells (MCF-7) | 24918059 |
RLID:01002058 | Nucleus | Neural progenitor cells | 21363885 |
RLID:11002584 | Exosome | Serum | 18589210 |
RLID:11002585 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
RLID:11002586 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11002587 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11002588 | Exosome | Renal cancer cells | 21670082 |
RLID:11002589 | Exosome | Brain tissue | 23382797 |
RLID:11002591 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11002592 | Exosome | Serum | 25349172 |
RLID:11002593 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
RLID:11002594 | Microvesicle | Seminal plasma | 23539611 |
RLID:11002595 | Microvesicle | Follicular fluid | 23666971 |
RLID-D:11000129 | Exosome | B lymphoblastoid cells|Chronic lymphocytic leukemia cells|Mast cells|Seminal fluid | |
RLID-D:11000430 | Microvesicle | Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-342-3p | Diffuse large b cell lymphoma | MNDR-E-MI-42082 |
MNDR | hsa-miR-342-3p | Splenic marginal zone lymphoma | MNDR-E-MI-42083 |
MNDR | hsa-miR-342-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-42084 |
MNDR | hsa-miR-342-3p | Oral squamous cell carcinoma | MNDR-E-MI-42085 |
MNDR | hsa-miR-342-3p | B cell lymphoma of malt type | MNDR-E-MI-42086 |
MNDR | hsa-miR-342-3p | Lymphoma | MNDR-E-MI-42087 |
MNDR | hsa-miR-342-3p | Lymphoma non-hodgkin | MNDR-E-MI-42088 |
MNDR | hsa-miR-342-3p | Cutaneous t cell lymphoma | MNDR-E-MI-42089 |
MNDR | hsa-miR-342-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-42090 |
MNDR | hsa-miR-342-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-42091 |
MNDR | hsa-miR-342-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-42092 |
MNDR | hsa-miR-342-3p | Acute promyelocytic leukemia | MNDR-E-MI-42093 |
MNDR | hsa-miR-342-3p | Breast cancer luminal | MNDR-E-MI-42094 |
MNDR | hsa-miR-342-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-42095 |
MNDR | hsa-miR-342-3p | B cell acute lymphoblastic leukemia | MNDR-E-MI-42096 |
MNDR | hsa-miR-342-3p | Prostate cancer | MNDR-E-MI-42097 |
MNDR | hsa-miR-342-3p | Gastric cancer | MNDR-E-MI-42098 |
MNDR | hsa-miR-342-3p | Gastric lymphoma | MNDR-E-MI-42099 |
MNDR | hsa-miR-342-3p | Alzheimer disease | MNDR-E-MI-42100 |
MNDR | hsa-miR-342-3p | Intracranial aneurysm | MNDR-E-MI-42101 |
MNDR | hsa-miR-342-3p | Dysautonomia familial | MNDR-E-MI-42102 |
MNDR | hsa-miR-342-3p | Head and neck cancer | MNDR-E-MI-42103 |
MNDR | hsa-miR-342-3p | Leukemia | MNDR-E-MI-42104 |
MNDR | hsa-miR-342-3p | Huntington disease | MNDR-E-MI-42105 |
MNDR | hsa-miR-342-3p | Chorea | MNDR-E-MI-42106 |
MNDR | hsa-miR-342-3p | Cardiovascular disease | MNDR-E-MI-42107 |
MNDR | hsa-miR-342-3p | Neurodegenerative diseases | MNDR-E-MI-42108 |
MNDR | hsa-miR-342-3p | Lung cancer | MNDR-E-MI-42109 |
MNDR | hsa-miR-342-3p | Parkinson disease | MNDR-E-MI-42110 |
MNDR | hsa-miR-342-3p | Machado-joseph disease | MNDR-E-MI-42111 |
MNDR | hsa-miR-342-3p | Breast cancer | MNDR-E-MI-42112 |
MNDR | hsa-miR-342-3p | Pancreatic cancer | MNDR-E-MI-42113 |
MNDR | hsa-miR-342-3p | Rectum adenocarcinoma | MNDR-E-MI-42114 |
MNDR | hsa-miR-342-3p | Nephroblastoma | MNDR-E-MI-42115 |
MNDR | hsa-miR-342-3p | Colon cancer | MNDR-E-MI-42116 |
MNDR | hsa-miR-342-3p | Colon adenocarcinoma | MNDR-E-MI-42117 |
MNDR | hsa-miR-342-3p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-42118 |
MNDR | hsa-miR-342-3p | Familial ovarian cancer | MNDR-E-MI-42119 |
MNDR | hsa-miR-342-3p | Prostate adenocarcinoma | MNDR-E-MI-42120 |
MNDR | hsa-miR-342-3p | Kidney cancer | MNDR-E-MI-42121 |
MNDR | hsa-miR-342-3p | Carcinoma ductal breast | MNDR-E-MI-42122 |
MNDR | hsa-miR-342-3p | Glioblastoma | MNDR-E-MI-42123 |
MNDR | hsa-miR-342-3p | Glioma | MNDR-E-MI-42124 |
MNDR | hsa-miR-342-3p | Chordoma | MNDR-E-MI-42125 |
MNDR | hsa-miR-342-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-42126 |
MNDR | hsa-miR-342-3p | Osteosarcoma | MNDR-E-MI-42127 |
MNDR | hsa-miR-342-3p | Breast carcinoma | MNDR-E-MI-42128 |
MNDR | hsa-miR-342-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-42129 |
MNDR | hsa-miR-342-3p | Meningioma | MNDR-E-MI-42130 |
MNDR | hsa-miR-342-3p | Liver cancer | MNDR-E-MI-42131 |
MNDR | hsa-miR-342-3p | Gastric adenocarcinoma | MNDR-E-MI-42132 |
MNDR | hsa-miR-342-3p | Lung squamous cell carcinoma | MNDR-E-MI-42133 |
MNDR | hsa-miR-342-3p | Carcinoma lung non-small-cell | MNDR-E-MI-42134 |
MNDR | hsa-miR-342-3p | Lung adenocarcinoma | MNDR-E-MI-42135 |
MNDR | hsa-miR-342-3p | Thyroid carcinoma | MNDR-E-MI-42136 |
MNDR | hsa-miR-342-3p | Cervical cancer | MNDR-E-MI-42137 |
MNDR | hsa-miR-342-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-42138 |
MNDR | hsa-miR-342-3p | Carcinoma renal cell | MNDR-E-MI-42139 |
MNDR | hsa-miR-342-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-42140 |
MNDR | hsa-miR-342-3p | Clear cell renal cell carcinoma | MNDR-E-MI-42141 |
MNDR | hsa-miR-342-3p | Cholangiocarcinoma | MNDR-E-MI-42142 |
MNDR | hsa-miR-342-3p | Lung small cell carcinoma | MNDR-E-MI-42143 |
MNDR | hsa-miR-342-3p | Variant creutzfeldt-jakob disease | MNDR-E-MI-42144 |
MNDR | hsa-miR-342-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-42145 |
MNDR | hsa-miR-342-3p | T acute lymphoblastic leukemia | MNDR-E-MI-42146 |
MNDR | hsa-miR-342-3p | Acute t cell leukemia | MNDR-E-MI-42147 |
MNDR | hsa-miR-342-3p | Prion disease | MNDR-E-MI-42148 |
MNDR | hsa-miR-342-3p | Breast invasive carcinoma | MNDR-E-MI-42149 |
MNDR | hsa-miR-342-3p | Hepatocellular carcinoma | MNDR-E-MI-42150 |
MNDR | hsa-miR-342-3p | Familiar ovarian carcinoma | MNDR-E-MI-42151 |
MNDR | hsa-miR-342-3p | B-cell lymphoma | MNDR-E-MI-42152 |
MNDR | hsa-miR-342-3p | Rheumatoid arthritis | MNDR-E-MI-42153 |
MNDR | hsa-miR-342-3p | T-cell leukemia | MNDR-E-MI-42154 |
MNDR | hsa-miR-342-3p | Malignant pleural mesothelioma | MNDR-E-MI-42155 |
MNDR | hsa-miR-342-3p | Retinoblastoma | MNDR-E-MI-42156 |
MNDR | hsa-miR-342-3p | Neuroblastoma | MNDR-E-MI-42157 |
MNDR | hsa-miR-342-3p | Hodgkin lymphoma | MNDR-E-MI-42158 |
MNDR | hsa-miR-342-3p | Burkitt lymphoma | MNDR-E-MI-42159 |
MNDR | hsa-miR-342-3p | Tonsil cancer | MNDR-E-MI-42160 |
MNDR | hsa-miR-342-3p | Neuromyelitis optica | MNDR-E-MI-42161 |
MNDR | hsa-miR-342-3p | Skin cutaneous melanoma | MNDR-E-MI-42162 |
MNDR | hsa-miR-342-3p | Skin melanoma | MNDR-E-MI-42163 |
MNDR | hsa-miR-342-3p | Colorectal cancer | MNDR-E-MI-42164 |
MNDR | hsa-miR-342-3p | Nasopharynx carcinoma | MNDR-E-MI-42165 |
MNDR | hsa-miR-342-3p | Multiple myeloma | MNDR-E-MI-42166 |
MNDR | hsa-miR-342-3p | Uterine cervical neoplasms | MNDR-E-MI-42167 |
MNDR | hsa-miR-342-3p | Nasopharyngeal cancer | MNDR-E-MI-42168 |
MNDR | hsa-miR-342-3p | Prostatic neoplasms | MNDR-E-MI-42169 |
MNDR | hsa-miR-342-3p | Sleep deprivation | MNDR-E-MI-42170 |
MNDR | hsa-miR-342-3p | Epstein-barr virus infections | MNDR-E-MI-42171 |
MNDR | hsa-miR-342-3p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-42172 |
MNDR | hsa-miR-342-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-42173 |
MNDR | hsa-miR-342-3p | Stroke lacunar | MNDR-E-MI-42174 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ANKRD49 | Homo sapiens | RR00081534 |
TOP